44
Growth Score in past quarter
pts
Heat Score 44 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3047851
OncomiR focuses on miR research for cancer progression.
About the Company
OncomiR operates in the biotechnology sector, concentrating on the research and development of microRNAs that affect cancer progression. The company applies a combinatorial research method to identify miRs that either contribute to or suppress the development of cancers, with particular attention to prostate cancer. It uses a distinct group of
prostate cancer cell lines to explore these mechanisms, seeking to identify molecular targets that may serve as diagnostic indicators or therapeutic intervention points. It studies specific miRs such as miR-21 to investigate their role in posttranscriptional regulation, with an emphasis on understanding cancer at the molecular level.